Journal
ACS MEDICINAL CHEMISTRY LETTERS
Volume 9, Issue 5, Pages 462-467Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acsmedchemlett.8b00076
Keywords
Carbonic anhydrase inhibitors (CAIs); diabetic pathology; selenium; metalloenzymes; organoselenium
Categories
Ask authors/readers for more resources
A series of novel selenides bearing benzene sulfonamide moieties was synthesized and investigated for their inhibition on six human (h) carbonic anhydrase (CA, EC 4.2.1.1) isoforms such as the physiologically relevant hCA I, II, VA, VB, VII, and IX and the X-ray complex in adduct with hCA II for some of them investigated. These enzymes are involved in a variety of diseases including glaucoma, retinitis pigmentosa, epilepsy, arthritis, metabolic disorders, and cancer. The investigated compounds showed potent inhibitory action against hCA VA, VII, and IX, in the low nanomolar range, thus making them of interest for the development of isoform-selective inhibitors and as candidates for various biomedical applications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available